ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Citizens Committee Notes Broad Support For NCI Funds

August 24, 1979

NCI To Recomplete Frederick Contract To Start In 1977

October 17, 1975

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

In Brief: Breakthrough Prize Awarded to 11 Scientists

March 8, 2013

McCain Surgery Puzzles Melanoma Experts, But Some Clues Found in Reporters’ Notes.

October 24, 2008

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978